Bastow 1983a.
Methods | Randomised clinical trial, hospital in UK | |
Participants | 122 hospitalised adults with fractured neck of femur and assessed as thin (1 ‐ 2 SDs below the mean), at nutritional risk due to being frail elderly with hip fracture Only women Mean age = 80 years Exclusion criteria: severe dementia or serious concomitant physical disorders, e.g. stroke |
|
Interventions | Experimental group: an overnight feed of 1 litre Clinifeed Iso (4 ‐ 2 MJ (1000 kcal), including 28 g protein). It was started within 5 days of operation and delivered over 8 hrs each night through a fine bore soft nasogastric tube using a peristaltic pump. Tube‐feeding was continued until the adult was discharged from the ward, did not tolerate the tube or died.(n = 39) Control group: no intervention(n = 35) Co‐interventions: both control and tube‐fed adults ate a normal ward diet during the day and were given free access to snacks and drinks. |
|
Outcomes | Weight, upper arm circumference, triceps skinfold thickness, mortality, food intake, length of hospital stay, mobility, plasma protein | |
Study dates | Not stated | |
Notes | Same trial as Bastow 1983b but with the participants characterised as 'thin'. We could not obtain any contact information on the author. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Not described |
Allocation concealment (selection bias) | Unclear risk | Not described |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Not described |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Not described |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | The number of participants with incomplete data was not reported. |
Selective reporting (reporting bias) | Unclear risk | No protocol could be obtained and the trial did not report all‐cause mortality and serious adverse events. |
For‐profit bias | High risk | One of the authors was supported by a grant from Roussell Laboratories Ltd. |
Other bias | Low risk | The trial appeared to be free of other components that could put it at risk of bias. |